Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Study of Barrett's Esophagus: What Are the Factors of Progression (BEST)

This study has suspended participant recruitment.
(The protocol is being reviewed and potentially revised. Recruitment is currently suspended.)
Sponsor:
Collaborators:
TAP Pharmaceutical Products Inc.
Kansas City Veteran Affairs Medical Center
Information provided by (Responsible Party):
PRATEEK SHARMA, Midwest Biomedical Research Foundation
ClinicalTrials.gov Identifier:
NCT00586404
First received: December 21, 2007
Last updated: October 19, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: November 2017
  Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)